Lv2
134 积分 2025-06-15 加入
The challenge of defining metabolic dysfunction and alcohol-associated liver disease
1个月前
已完结
Liver‐Pancreas Fat Deposition: Impact on Cardiometabolic Multimorbidity and Cardiac Dysfunction
1个月前
已完结
Editorial: Combination Therapies for MASH : A Step Forward or More Complexity?
1个月前
已完结
Trends in the Prevalence of Clinical and Preclinical Obesity Among US Adults by Social Determinants of Health
1个月前
已完结
Combination therapies for metabolic dysfunction-associated steatohepatitis: challenges and opportunities
1个月前
已完结
MASLD as a systemic metabolic disease: expanding the scope of cardiovascular-kidney-metabolic (CKM) syndrome
1个月前
已完结
Hepatocyte DDIT4 aggravates MASH progression through GPX4-mediated ferroptosis
1个月前
已完结
Burden of metabolic diseases, 1990-2023, with forecasts to 2030 for the Asia-Pacific region
1个月前
已完结
Pharmacotherapy for metabolic dysfunction-associated steatohepatitis: heart–liver co-management
1个月前
已完结
Validation of a data-driven clustering model for MASLD: Evidence from three large-scale Asian cohorts
1个月前
已完结
皖公网安备34019202002308
